Teva Pharmaceutical Industries Ltd. — Capital/Financing Update 2011

Jan 24, 2011

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 24/01/2011              Time of broadcast: 09:11 09:07:39

Reference: 2011-02-025983

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Teva Enters Into $1.5 Billion Syndicated Credit Facility
credit_isa.pdf

Please find the attached press release issued today in the U.S. and its non binding translation into Hebrew.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 30/12/2010
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: eyal@teva.co.il 2